Literature DB >> 16453013

Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes.

Giuseppe Remuzzi1, Ariela Benigni, Andrea Remuzzi.   

Abstract

The incidence of chronic kidney diseases is increasing worldwide, and these conditions are emerging as a major public health problem. While genetic factors contribute to susceptibility and progression of renal disease, proteinuria has been claimed as an independent predictor of outcome. Reduction of urinary protein levels by various medications and a low-protein diet limits renal function decline in individuals with nondiabetic and diabetic nephropathies to the point that remission of the disease and regression of renal lesions have been observed in experimental animals and even in humans. In animal models, regression of glomerular structural changes is associated with remodeling of the glomerular architecture. Instrumental to this discovery were 3D reconstruction studies of the glomerular capillary tuft, which allowed the quantification of sclerosis volume reduction and capillary regeneration upon treatment. Regeneration of capillary segments might result from the contribution of resident cells, but progenitor cells of renal or extrarenal origin may also have a role. This review describes recent advances in our understanding of the mechanisms and mediators underlying renal tissue repair ultimately responsible for regression of renal injury.

Entities:  

Mesh:

Year:  2006        PMID: 16453013      PMCID: PMC1359063          DOI: 10.1172/JCI27699

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  117 in total

1.  Albuminuria as early test for vascular disease.

Authors:  Giuseppe Remuzzi; Jan J Weening
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

2.  Three-dimensional morphometric analysis of segmental glomerulosclerosis in the rat.

Authors:  A Remuzzi; R Pergolizzi; M S Mauer; T Bertani
Journal:  Kidney Int       Date:  1990-11       Impact factor: 10.612

Review 3.  Autosomal dominant polycystic kidney disease.

Authors:  P A Gabow
Journal:  N Engl J Med       Date:  1993-07-29       Impact factor: 91.245

4.  Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.

Authors:  Anthony H Barnett; Stephen C Bain; Paul Bouter; Bengt Karlberg; Sten Madsbad; Jak Jervell; Jukka Mustonen
Journal:  N Engl J Med       Date:  2004-10-31       Impact factor: 91.245

5.  Preventing microalbuminuria in type 2 diabetes.

Authors:  Piero Ruggenenti; Anna Fassi; Anelja Parvanova Ilieva; Simona Bruno; Ilian Petrov Iliev; Varusca Brusegan; Nadia Rubis; Giulia Gherardi; Federica Arnoldi; Maria Ganeva; Bogdan Ene-Iordache; Flavio Gaspari; Annalisa Perna; Antonio Bossi; Roberto Trevisan; Alessandro R Dodesini; Giuseppe Remuzzi
Journal:  N Engl J Med       Date:  2004-10-31       Impact factor: 91.245

6.  Renal protective effect of enalapril in diabetic nephropathy.

Authors:  S Björck; H Mulec; S A Johnsen; G Nordén; M Aurell
Journal:  BMJ       Date:  1992-02-08

7.  Assessment of risk of overt nephropathy in diabetic patients from albumin excretion in untimed urine specimens.

Authors:  R G Nelson; W C Knowler; D J Pettitt; M F Saad; M A Charles; P H Bennett
Journal:  Arch Intern Med       Date:  1991-09

8.  Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions.

Authors:  M Ikoma; T Kawamura; Y Kakinuma; A Fogo; I Ichikawa
Journal:  Kidney Int       Date:  1991-08       Impact factor: 10.612

9.  Relationship of systemic blood pressure to nephropathology in insulin-dependent diabetes mellitus.

Authors:  S M Mauer; D E Sutherland; M W Steffes
Journal:  Kidney Int       Date:  1992-04       Impact factor: 10.612

10.  Prognosis of untreated patients with idiopathic membranous nephropathy.

Authors:  A Schieppati; L Mosconi; A Perna; G Mecca; T Bertani; S Garattini; G Remuzzi
Journal:  N Engl J Med       Date:  1993-07-08       Impact factor: 91.245

View more
  181 in total

1.  Lipocalin 2 is essential for chronic kidney disease progression in mice and humans.

Authors:  Amandine Viau; Khalil El Karoui; Denise Laouari; Martine Burtin; Clément Nguyen; Kiyoshi Mori; Evangéline Pillebout; Thorsten Berger; Tak Wah Mak; Bertrand Knebelmann; Gérard Friedlander; Jonathan Barasch; Fabiola Terzi
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

2.  Animal models of regression/progression of kidney disease.

Authors:  Beom Jin Lim; Hai-Chun Yang; Agnes B Fogo
Journal:  Drug Discov Today Dis Models       Date:  2014

3.  Angiotensin AT₂ receptor stimulation inhibits early renal inflammation in renovascular hypertension.

Authors:  Luis C Matavelli; Jiqian Huang; Helmy M Siragy
Journal:  Hypertension       Date:  2010-12-28       Impact factor: 10.190

4.  TGF-alpha mediates genetic susceptibility to chronic kidney disease.

Authors:  Denise Laouari; Martine Burtin; Aurélie Phelep; Carla Martino; Evangeline Pillebout; Xavier Montagutelli; Gérard Friedlander; Fabiola Terzi
Journal:  J Am Soc Nephrol       Date:  2010-12-23       Impact factor: 10.121

5.  Proteins and renal fibrosis: low-protein diets induce Kruppel-like factor-15, limiting renal fibrosis.

Authors:  Yanlin Wang; William E Mitch
Journal:  Kidney Int       Date:  2011-05       Impact factor: 10.612

6.  Basic research: Podocyte progenitors and ectopic podocytes.

Authors:  Laura Lasagni; Paola Romagnani
Journal:  Nat Rev Nephrol       Date:  2013-11-12       Impact factor: 28.314

7.  Tight metabolic control plus ACE inhibitor therapy improves GSD I nephropathy.

Authors:  Gyongyi O Okechuku; Lawrence R Shoemaker; Monika Dambska; Laurie M Brown; Justin Mathew; David A Weinstein
Journal:  J Inherit Metab Dis       Date:  2017-06-13       Impact factor: 4.982

Review 8.  Efficacy and safety of Flos Abelmoschus manihot (Malvaceae) on type 2 diabetic nephropathy: A systematic review.

Authors:  Yi-Zhi Chen; Zhi-Xiang Gong; Guang-Yan Cai; Qing Gao; Xiang-Mei Chen; Li Tang; Ri-Bao Wei; Jian-Hui Zhou
Journal:  Chin J Integr Med       Date:  2014-12-09       Impact factor: 1.978

9.  Response of urinary liver-type fatty acid-binding protein to contrast media administration has a potential to predict one-year renal outcome in patients with ischemic heart disease.

Authors:  Daishi Fujita; Masao Takahashi; Kent Doi; Mitsuru Abe; Junichi Tazaki; Arihiro Kiyosue; Masahiro Myojo; Jiro Ando; Hideo Fujita; Eisei Noiri; Takeshi Sugaya; Yasunobu Hirata; Issei Komuro
Journal:  Heart Vessels       Date:  2014-02-20       Impact factor: 2.037

Review 10.  Inflammation regulates fibroblast growth factor 23 production.

Authors:  Connor Francis; Valentin David
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-07       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.